These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 6127035)
1. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035 [TBL] [Abstract][Full Text] [Related]
2. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase in schizophrenia: a meta-analysis. Marcolin MA; Davis JM Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426 [TBL] [Abstract][Full Text] [Related]
4. Human platelet MAO in drug-free and medicated schizophrenic patients. Friedhoff AJ; Miller JC; Weisenfreund J Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104 [TBL] [Abstract][Full Text] [Related]
5. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D; Maj M; Ariano MG; Salvati A Encephale; 1985; 11(1):31-4. PubMed ID: 2859981 [TBL] [Abstract][Full Text] [Related]
6. Kinetic constants of platelet monoamine oxidase in schizophrenia. Jackman HL; Meltzer HY Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590 [TBL] [Abstract][Full Text] [Related]
9. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Takahashi S; Yamane H; Tani N Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524 [TBL] [Abstract][Full Text] [Related]
10. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754 [TBL] [Abstract][Full Text] [Related]
11. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder. Malas KL; van Kammen DP Am J Psychiatry; 1983 Jun; 140(6):794-6. PubMed ID: 6846644 [TBL] [Abstract][Full Text] [Related]
13. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment? Del Vecchio M; Maj M; D'Ambrosio A; Kemali D Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302 [TBL] [Abstract][Full Text] [Related]
14. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity. Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337 [TBL] [Abstract][Full Text] [Related]
16. Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response. Hitzemann RJ; Sautter F; Hitzemann B; Hirschowitz J; Garver DL Psychiatry Res; 1984 Mar; 11(3):211-21. PubMed ID: 6587414 [TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity in major psychoses. Gattaz WF Mod Probl Pharmacopsychiatry; 1983; 19():315-20. PubMed ID: 6135152 [No Abstract] [Full Text] [Related]
18. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J; Thomas KM Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [TBL] [Abstract][Full Text] [Related]
19. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients. Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610 [TBL] [Abstract][Full Text] [Related]